B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 600 KRW -2.13% Market Closed
Market Cap: 469.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioNote Inc
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Total Liabilities & Equity
â‚©1.6T
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Liabilities & Equity
â‚©19.9T
CAGR 3-Years
56%
CAGR 5-Years
40%
CAGR 10-Years
24%
SK Bioscience Co Ltd
KRX:302440
Total Liabilities & Equity
â‚©1.9T
CAGR 3-Years
49%
CAGR 5-Years
36%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Liabilities & Equity
â‚©943B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Liabilities & Equity
â‚©601.5B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Liabilities & Equity
â‚©306.3B
CAGR 3-Years
6%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
469.5B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
6 138.02 KRW
Undervaluation 25%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Total Liabilities & Equity?
Total Liabilities & Equity
1.6T KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Total Liabilities & Equity amounts to 1.6T KRW.

What is BioNote Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
23%

Over the last year, the Total Liabilities & Equity growth was -9%. The average annual Total Liabilities & Equity growth rates for BioNote Inc have been 23% over the past three years .

Back to Top